Kite Pharma Investors Balk At $11.9B Gilead Deal
Kite Pharma Inc. didn't ask for enough money from Gilead Sciences Inc. when it agreed to be bought last month, according to a proposed class of investors who alleged in a...To view the full article, register now.
Already a subscriber? Click here to view full article